JCHOR
Journal of Current Hematology & Oncology Research

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge.

ISSN: Active
eISSN: 2980-0854
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Association of ABO and Rh blood groups with survival and clinicopathological characteristics in patients with gastric adenocarcinoma: a single-center retrospective study
Abstract
Aims: Identifying factors affecting the prognosis of gastric cancer is clinically important. Although ABO and Rh blood groups have been suggested to have a prognostic role in various malignancies, their impact in gastric cancer remains unclear. This study aimed to evaluate the association of ABO and Rh blood groups with clinicopathological characteristics and overall survival in patients with gastric adenocarcinoma.
Methods: In this retrospective single-center study, 320 patients diagnosed with gastric adenocarcinoma were included. Demographic and clinical data were obtained from electronic medical records. Overall survival was analyzed using the Kaplan–Meier method, and differences between groups were compared using the log-rank test. Cox regression analysis was performed to identify prognostic factors.
Results: The mean age of the patients was 70.2 ± 9.5 years, and 68.4% were male. Among clinicopathological characteristics, only surgical treatment showed a statistically significant association with ABO blood groups (p=0.047). The median overall survival was 15.8 months. No statistically significant association was found between ABO blood groups (p=0.223) or Rh factor (p=0.850) and overall survival. The presence of metastasis was significantly associated with overall survival (p<0.001). A statistically significant difference in overall survival was observed according to primary surgical treatment status (p<0.001). In multivariate analysis, only surgical treatment was identified as an independent prognostic factor (HR: 0.58; 95% CI: 0.40–0.85; p=0.005).
Conclusion: ABO and Rh blood groups were not found to have a significant prognostic impact on overall survival in patients with gastric adenocarcinoma. In contrast, clinical factors such as metastasis and surgical treatment were identified as key determinants of survival. These findings suggest that prognosis in gastric cancer is more closely related to disease extent and treatment strategies rather than blood group characteristics.

Keywords : ABO blood group, gastric cancer, prognostic factors, Rh factor, survival

Download Article


1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide. CA Cancer J Clin. 2024;74(3):229-263. doi:10.3322/caac.21834
2. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020. CA Cancer J Clin. 2021;71(3):209-249. doi:10.3322/caac.21660
3. Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer. Lancet. 2020; 396(10251):635-648. doi:10.1016/S0140-6736(20)31288-5
4. Edgren G, Hjalgrim H, Rostgaard K, et al. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol. 2010;172(11):1280-1285.
5. Rummel SK, Ellsworth RE. The role of the histoblood ABO group in cancer. Future Sci OA. 2016;2(2):FSO107. doi:10.4155/fsoa-2015-0012
6. Hakomori S. Antigen structure and genetic basis of histo-blood groups. Biochim Biophys Acta. 1999;1473(1):247-266. doi:10.1016/s0304-4165(99)00183-x
7. Wang Z, Liu L, Ji J, et al. ABO blood group system and gastric cancer: a case-control study and meta-analysis. Int J Mol Sci. 2012;13(10):13308-13321. doi:10.3390/ijms131013308
8. Xu YQ, Jiang TW, Cui YH, Zhao YL, Qiu LQ. Prognostic value of ABO blood group in patients with gastric cancer. J Surg Res. 2016;201(1):188-195. doi:10.1016/j.jss.2015.10.039
9. Sun W, Wen CP, Lin J, et al. ABO blood types and cancer risk—a cohort study of 339,432 subjects in Taiwan. Cancer Epidemiol. 2015;39(2):150-156. doi:10.1016/j.canep.2014.12.006
10. Vasan SK, Hwang J, Rostgaard K, et al. ABO blood group and risk of cancer: a register-based cohort study of 1.6 million blood donors. Cancer Epidemiol. 2016;44:40-43. doi:10.1016/j.canep.2016.06.005
11. He M, Wolpin B, Rexrode K, et al. ABO blood group and risk of cancer. Blood. 2012;120(25):499-505.
12. Zhang BL, He N, Huang YB, et al. ABO blood groups and risk of cancer: a meta-analysis. Asian Pac J Cancer Prev. 2014;15(11):4643-4650. doi:10.7314/apjcp.2014.15.11.4643
13. Dogan I, Gurbuz M, Aydin E, et al. Distributions and prognostic effects of ABO/Rh blood groups in patients with HER2/neu positive gastric and gastroesophageal junction cancer. J Cancer Res Ther. 2023;19(Suppl 2):S747-S751. doi:10.4103/jcrt.jcrt_1520_22
14. Franchini M, Liumbruno GM, Lippi G. The prognostic value of ABO blood group in cancer patients. Blood Transfus. 2016;14(5):434-440. doi:10.2450/2015.0164-15
15. Yamamoto F. ABO blood group system and cancer. Transfus Med Rev. 2021;35(1):1-7.
16. Chen Z, Yang SH. ABO gene polymorphism and inflammation pathways. Front Immunol. 2022;13:1-10.
17. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517): 202-209. doi:10.1038/nature13480
18. Tuncel ET, Kut E. Prognostic relationship between the ABO blood groups and metastatic gastric cancer. Cureus. 2023;15(2):e34837. doi:10.7759/cureus.34837
19. Lordick F, Carneiro F, Cascinu S, et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(10):1005-1020. doi:10.1016/j.annonc.2022.07.004
20. Al-Batran SE, Homann N, Pauligk C, et al. Effect of neoadjuvant chemotherapy followed by surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction cancer: the AIO-FLOT3 trial. JAMA Oncol. 2017;3(9):1237-1244. doi:10.1001/jamaoncol.2017.0515
Article available in :
Volume 4, Issue 3, 2026
Page : 99-104
https://doi.org/10.51271/JCHOR-0090
Article Information
Received : 16 Nis 2026
Accepted : 06 Tem 2026
Published : 08 Ağu 2026
Corresponding Author :

Erdoğan Şeyran: Department of Medical Oncology, Van Training and Research Hospital, Van, Turkiye

[email protected]
Citation : Şeyran E, Gökmen A. Association of ABO and Rh blood groups with survival and clinicopathological characteristics in patients with gastric adenocarcinoma: a single-center retrospective cohort study. J Curr Hematol Oncol Res. 2026;4(3):99-104. doi:10.51271/JCHOR-0090

Read: 5
Download : 4
Cited: 0
_Footer